Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • SEC, FDA sign info-sharing agreement as a ‘signal to the market’ on insider trading

SEC, FDA sign info-sharing agreement as a ‘signal to the market’ on insider trading

September 2, 2026Posted inBiotechnology

The SEC and the FDA have signed a three-year agreement to step up cooperation and information-sharing capabilities aiming to improve each organization’s regulatory and enforcement missions.

Post navigation

Previous Post
TScan axes 75% of workforce to make room for solid tumor programs
Next Post
Teva autoimmune antibody notches ph. 2 win in celiac disease

Recent Posts

  • Modeling Reveals How Silica Gold Nanoparticles Reshape Optical Energy and Fields
  • Intravenous Iron Formulations Spur Divergent Muscle Recovery in Iron Deficiency Anaemia
  • SAR and optical data fuse in dynamic graph network to classify sea ice with 96.69% accuracy
  • Grid access cuts solar adoption odds in Cameroon, study finds
  • CT Histogram Radiomics Accurately Distinguishes Middle Ear Cholesteatoma

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top